AIM
RETA

Acrospire Investment Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Acrospire Investment Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,137
Closed -$68K – 2579
2016
Q4 		$68K Buy
3,137
+2,437
+348% +$52.8K 0.03% 1195
2016
Q3 		$18K Buy
700
+400
+133% +$10.3K 0.01% 1541
2016
Q2 		$6K Buy
+300
New +$6K ﹤0.01% 1844